NPI: 1205070984 · MATTHEWS, NC 28105 · Pediatric Adolescent Medicine Physician · NPI assigned 04/27/2009
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 04/27/2009 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,344 | $190K |
| 2019 | 5,339 | $259K |
| 2020 | 4,684 | $207K |
| 2021 | 13,573 | $358K |
| 2022 | 27,898 | $492K |
| 2023 | 23,480 | $332K |
| 2024 | 15,087 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5,970 | 4,969 | $582K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,612 | 7,060 | $557K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5,528 | 4,646 | $202K |
| 99199 | Unlisted special service, procedure or report | 58,362 | 56,831 | $191K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 674 | 594 | $66K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 534 | 399 | $53K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 468 | 360 | $44K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,869 | 1,473 | $36K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,742 | 1,672 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 515 | 407 | $25K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 603 | 482 | $18K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 252 | 195 | $16K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,258 | 1,021 | $12K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 331 | 316 | $9K |
| 96127 | 1,802 | 1,518 | $7K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 64 | 50 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 240 | 120 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 347 | 300 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 220 | 213 | $3K |
| 90461 | 1,356 | 1,078 | $2K | |
| 90686 | 1,501 | 1,347 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | 56 | 40 | $2K |
| D1206 | Topical application of fluoride varnish | 56 | 40 | $867.60 |
| 92552 | 616 | 570 | $503.38 | |
| 99173 | 1,476 | 1,293 | $247.68 | |
| 87081 | 30 | 28 | $191.97 | |
| 90674 | 262 | 205 | $175.12 | |
| 96161 | 30 | 24 | $112.97 | |
| 90670 | 204 | 164 | $0.00 | |
| 99000 | 227 | 171 | $0.00 | |
| 90698 | 164 | 124 | $0.00 | |
| 90744 | 15 | 12 | $0.00 | |
| 99174 | 21 | 13 | $0.00 |